Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
German finance minister sees advantages of smartphones in schools - 2Venezuelans in Madrid celebrate Maduro's capture
- 3Many European nations want Israel to cancel 19 new settlement plans
- 4Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list
- 5Consumers advised to dispose of 19 cooking pans due to lead leaching risk, FDA reports
- 'We are ready': NASA still on track to launch Artemis 2 astronauts to the moon April 1
- This Week In Space podcast: Episode 192 — Space, 2026!
- Child influencers helped power a booming industry. It's time for a reckoning.
- When Would it be a good idea for you to Look for Help from a Criminal Legal counselor?
- Make your choice for the sweet that transports you to its nation of beginning!
- Flu season is ramping up, and some experts are "pretty worried"
- Glamour Shots once ruled the mall. I went to one of the last ones standing.
- Clovis Unified students spend spring break traveling through China
- The most effective method to Engage in Local area Making arrangements for 5G Pinnacle Establishments
